This article is freely available to all

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Dementia with Lewy bodies (DLB) is characterizedclinically by progressive and fluctuating cognitive decline, visualhallucinations, and parkinsonism.1 Some studies have reportedthat cholinesterase inhibitors are at least partiallybeneficial for treating patients with DLB.2-4 However, Shea etal.5 reported that cholinesterase inhibitors occasionally causeddeterioration of parkinsonian symptoms in patients with DLB.’ ‹